BACKGROUND:
The immense comorbidity among disorders could be ascribed to common trans-diagnostic processes. The term trans-diagnostic has been of interest in both pathology and psychology. Trans-diagnostic treatments were created as opposed to treatments based on single-diagnosis treatments. It addresses the common underlying mechanisms in a range of comorbid disorders. Trans-diagnostic treatment is one of the new psychological treatments, and its efficacy has been proven on many psychological variables. The main focus of the current study is on designing unified trans-diagnostic interventions and their efficacy on the shared mechanisms of comorbid obsessive personality disorder with anxiety, depression, and obsessive-compulsive disorder.
MATERIALS AND METHODS:
the sequential transformative strategy has two stages; qualitative and quantitative. In The first and qualitative section of the research, explanatory research will be carried out to investigate the trans-diagnostic intervention using a systematic review. To validate the trans-diagnostic intervention, and simultaneously with the trans-diagnostic intervention, a questionnaire has been prepared and given to 10 psychology experts and professionals in the treatment field concerning content validity by evaluators.
CONCLUSION:
Designing unified trans-diagnosis interventions and their efficacy on the common mechanisms of comorbid obsessive personality disorder with anxiety, depression, and obsessive-compulsive disorder is an effective treatment method for helping those suffering from a personality disorder. Clinical psychologists, psychology experts, psychiatrists, and mental health experts are all the immediate beneficiaries of this study. Moreover, clients could benefit from this intervention with less money and time.
Introduction: Patients with dental anxiety avoid receiving medical care. This anxiety poses a threat to oral health. The present study aimed to investigate the effectiveness of muscle relaxation training and mindfulness training on fear and resilience in patients with dental anxiety. Methods: This was a clinical trial (pretest-posttest design and a control group). The statistical population comprised all patients with dental anxiety who went to dental clinics in the city of Ahvaz in 2018-2019. The research sample included 45 patients with dental anxiety selected through convenience sampling. The participants were randomly divided into two experimental (muscle relaxation training and mindfulness training) and one control group (n=15 each). The research tools included the Dental Fear Survey (DFS), the Connor-Davidson Resilience Scale (CD-RISC), and the Modified Dental Anxiety Scale (MDAS). Multivariate analysis of covariance was used to analyze the data. Results: The mean±standard deviation (SD) of the post-test scores of fear and resilience were 49.53±9.67 and 84.80±7.89 in the muscle relaxation training group and 58.26±12.67 and 55.60±8.83 in the mindfulness training group, which were significantly different from the control groups (83.80±3.50 and 40.46±5.65). Muscle relaxation training reduced fear and increased resilience in patients with dental anxiety in the experimental groups compared to the control group (P<0.001). Furthermore, in terms of fear and resilience in patients with dental anxiety, muscle relaxation training and mindfulness training were significantly different (P<0.001). Conclusion: In addition to decreasing fear, muscle relaxation training and mindfulness can increase resilience in patients with dental anxiety. Also, muscle relaxation training was more effective than mindfulness training in reducing fear and increasing resilience in patients with dental anxiety.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.